Paresthesia Treatment Market
Paresthesia Treatment Market Forecasts to 2030 - Global Analysis By Type (Chronic Paresthesia, Acute Paresthesia and Other Types), Treatment (Tropical Creams, Anticonvulsants, Immunosuppressant, Antivirals and Other Treatments), Cause, Distribution Channel, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $5.39 BN |
|
Projected Year Value (2030) |
US $7.89 BN |
|
CAGR (2023 - 2030) |
5.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Paresthesia Treatment Market is accounted for $5.39 billion in 2023 and is expected to reach $7.89 billion by 2030 growing at a CAGR of 5.6% during the forecast period. The Paresthesia Treatment Market refers to the economic domain encompassing the various products and services aimed at diagnosing, managing, and alleviating symptoms of paresthesia—a neurological condition characterized by abnormal sensations such as tingling, numbness, and burning. It provides a spectrum of therapeutic options, including pharmaceuticals, neuromodulation devices, and rehabilitation therapies, tailored to alleviate the symptoms of paresthesia and its underlying causes.
According to the World Health Organization, the number of people aged over 60 years and above was around 1 billion in 2020 and is projected to reach over 1.4 billion people by 2030.
Market Dynamics:
Driver:
Increasing incidences of chronic illnesses
As chronic conditions such as diabetes, neuropathy, and autoimmune disorders become more widespread, the incidence of paresthesia, characterized by abnormal sensations like tingling and numbness, has witnessed a proportional rise. Paresthesia often manifests as a symptom of underlying medical issues, prompting an increased demand for effective treatments and management strategies. Additionally, healthcare providers are compelled to address the growing patient pool seeking relief from paresthesia-related discomfort, fostering the expansion of the treatment market.
Restraint:
Possibility of adverse effects linked to specific treatment modalities
Certain patients may have negative reactions, discomfort, or complications from interventions like nerve stimulation or medication therapy. This may prevent these treatments from being widely used because patient and physician acceptance may be restricted due to worries about safety and tolerability. However, it is challenging because individual responses to treatments vary, so healthcare providers must carefully evaluate and customize interventions for each patient.
Opportunity:
Increasing need for neuromodulation treatments
Neuromodulation, encompassing various techniques such as spinal cord stimulation and peripheral nerve stimulation, has gained prominence as an effective approach in managing paresthesia and associated neurological disorders. With an increasing prevalence of chronic conditions like neuropathy and spinal disorders, there is a growing demand for advanced therapeutic interventions that directly target the nervous system to alleviate symptoms like tingling and numbness. Neuromodulation techniques offer a tailored and minimally invasive solution, providing patients with a viable alternative when traditional treatments prove insufficient.
Threat:
Negative consequences related to current treatment methods
The possibility of negative side effects and complications from current treatment modalities poses a serious threat to the paresthesia treatment market. Treatments for paresthesia that involve risks like infection, device malfunction, or unintentional nerve damage include spinal cord stimulation and medications. However, the market dominance of existing treatments may be threatened by developments in alternative therapies or emerging technologies. In order to lessen these risks in the ever-changing paresthesia treatment market, it will be essential to maintain the safety and effectiveness of current strategies and to consistently innovate.
Covid-19 Impact:
The paresthesia treatment market has been severely impacted by the COVID-19 pandemic. The creation and uptake of paresthesia treatments have slowed down as a result of disruptions in healthcare services, issues with the supply chain, and a shift in focus toward pandemic management. However, opportunities for online consultations and at-home treatments have been made possible by the growing emphasis on telemedicine and remote patient monitoring. It is anticipated to progressively rebound as the healthcare industry adjusts to the new normal, propelled by technological developments and the return of routine medical care.
The chronic paresthesia segment is expected to be the largest during the forecast period
The chronic paresthesia segment is expected to grow at a largest share. With a rising global incidence of chronic health conditions such as diabetes, peripheral neuropathy, and autoimmune disorders, a growing population is experiencing persistent and recurrent paresthesia. Chronic paresthesia, characterized by long-term or recurring abnormal sensations like tingling and numbness, necessitates sustained and effective treatment strategies. Moreover, this increasing prevalence has fueled a demand for targeted and enduring solutions, driving the expansion of the chronic paresthesia.
The retail pharmacy segment is expected to have the highest CAGR during the forecast period
Retail Pharmacy segment is projected to hold lucrative growth. As awareness about paresthesia and related neurological disorders increases, individuals seek accessible and convenient avenues for obtaining treatment and medications. Retail pharmacies serve as crucial distribution points for a wide array of pharmaceutical products, including those designed to alleviate symptoms of paresthesia. The ease of access to over-the-counter medications and prescription drugs at retail pharmacies enhances the availability of paresthesia treatments to a broad spectrum of patients.
Region with largest share:
Due to increasing prevalence of chronic diseases, coupled with a rapidly growing aging population in countries like China, India, and Japan, has led to a rising incidence of paresthesia-related conditions, the Asia-Pacific paresthesia treatment market has grown substantially. As awareness about neurological disorders and their management improves, there is a heightened demand for effective paresthesia treatments in the region. Additionally, the evolving healthcare infrastructure, favorable government initiatives, and a surge in healthcare spending contribute to the market's growth in the region.
Region with highest CAGR:
As the region's regulatory environment supports innovation, encouraging research and development activities in the field of neurology and neuromodulation, Europe region is growing at a rapid pace over the projected period. A surge in healthcare investments, coupled with a strong focus on patient-centric care, positions Europe as a hub for advancements in paresthesia treatment modalities. The market has grown as a result of medical technology advancements, increased healthcare spending, and growing awareness. Furthermore, research and development efforts have been fueled by regional partnerships between pharmaceutical companies and healthcare providers, which have resulted in novel treatment options in the region.
Key players in the market
Some of the key players in Paresthesia Treatment market include Abbott Laboratories, AstraZeneca, Baxter International Inc., Boston Scientific Corporation, Cipla Ltd, ElectroCore LLC, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Mylan N.V, Nevro Corp, Novartis AG, Pfizer Inc., Sanofi, Stimwave LLC, Stryker Corp and Teva Pharmaceutical Industries Ltd.
Key Developments:
In December 2023, AstraZeneca Pharma India Ltd. has signed a memorandum of understanding (MoU) with Roche Diagnostics India to improve diagnostics for breast cancer patients with a key focus to streamlining HER2 diagnostics with newer advancements in the field. As per the partnership, comprehensive training initiatives for pathologists and medical oncologists will be imparted. Training modules designed for oncologists will cover advances in HER-2 testing and HER-2 low interpretations.
In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain. The transaction includes an upfront cash payment of $850 million and undisclosed additional contingent payments based on sales performance over the next three years.
Types Covered:
• Chronic Paresthesia
• Acute Paresthesia
• Other Types
Treatments Covered:
• Tropical Creams
• Anticonvulsants
• Immunosuppressant
• Antivirals
• Other Treatments
Causes Covered:
• Nerve Compression
• Nerve Damage
• Metabolic Disorders
• Other Causes
Distribution Channels Covered:
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy
• Direct Tenders
• Other Distribution Channels
End Users Covered:
• Clinics
• Homecare
• Diagnosis Centers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Paresthesia Treatment Market, By Type
5.1 Introduction
5.2 Chronic Paresthesia
5.3 Acute Paresthesia
5.4 Other Types
6 Global Paresthesia Treatment Market, By Treatment
6.1 Introduction
6.2 Tropical Creams
6.2.1 Prilocaine
6.2.2 Lidocaine
6.2.3 Other Tropical Creams
6.3 Anticonvulsants
6.4 Immunosuppressant
6.4.1 Intravenous Gamma Globulin
6.4.2 Prednisone
6.4.3 Other Immunosuppressants
6.5 Antivirals
6.6 Other Treatments
7 Global Paresthesia Treatment Market, By Cause
7.1 Introduction
7.2 Nerve Compression
7.3 Nerve Damage
7.4 Metabolic Disorders
7.5 Other Causes
8 Global Paresthesia Treatment Market, By Distribution Channel
8.1 Introduction
8.2 Retail Pharmacy
8.3 Hospital Pharmacy
8.4 Online Pharmacy
8.5 Direct Tenders
8.6 Other Distribution Channels
9 Global Paresthesia Treatment Market, By End User
9.1 Introduction
9.2 Clinics
9.3 Homecare
9.4 Diagnosis Centers
9.5 Other End Users
10 Global Paresthesia Treatment Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abbott Laboratories
12.2 AstraZeneca
12.3 Baxter International Inc.
12.4 Boston Scientific Corporation
12.5 Cipla Ltd
12.6 ElectroCore LLC
12.7 Eli Lilly and Company
12.8 GlaxoSmithKline plc
12.9 Johnson & Johnson Services, Inc.
12.10 Merck & Co., Inc.
12.11 Mylan N.V
12.12 Nevro Corp
12.12 Novartis AG
12.14 Pfizer Inc.
12.15 Sanofi
12.16 Stimwave LLC
12.17 Stryker Corp
12.18 Teva Pharmaceutical Industries Ltd.
List of Tables
1 Global Paresthesia Treatment Market Outlook, By Country (2021-2030) ($MN)
2 Global Paresthesia Treatment Market Outlook, By Type (2021-2030) ($MN)
3 Global Paresthesia Treatment Market Outlook, By Chronic Paresthesia (2021-2030) ($MN)
4 Global Paresthesia Treatment Market Outlook, By Acute Paresthesia (2021-2030) ($MN)
5 Global Paresthesia Treatment Market Outlook, By Other Types (2021-2030) ($MN)
6 Global Paresthesia Treatment Market Outlook, By Treatment (2021-2030) ($MN)
7 Global Paresthesia Treatment Market Outlook, By Tropical Creams (2021-2030) ($MN)
8 Global Paresthesia Treatment Market Outlook, By Prilocaine (2021-2030) ($MN)
9 Global Paresthesia Treatment Market Outlook, By Lidocaine (2021-2030) ($MN)
10 Global Paresthesia Treatment Market Outlook, By Other Tropical Creams (2021-2030) ($MN)
11 Global Paresthesia Treatment Market Outlook, By Anticonvulsants (2021-2030) ($MN)
12 Global Paresthesia Treatment Market Outlook, By Immunosuppressant (2021-2030) ($MN)
13 Global Paresthesia Treatment Market Outlook, By Intravenous Gamma Globulin (2021-2030) ($MN)
14 Global Paresthesia Treatment Market Outlook, By Prednisone (2021-2030) ($MN)
15 Global Paresthesia Treatment Market Outlook, By Other Immunosuppressants (2021-2030) ($MN)
16 Global Paresthesia Treatment Market Outlook, By Antivirals (2021-2030) ($MN)
17 Global Paresthesia Treatment Market Outlook, By Other Treatments (2021-2030) ($MN)
18 Global Paresthesia Treatment Market Outlook, By Cause (2021-2030) ($MN)
19 Global Paresthesia Treatment Market Outlook, By Nerve Compression (2021-2030) ($MN)
20 Global Paresthesia Treatment Market Outlook, By Nerve Damage (2021-2030) ($MN)
21 Global Paresthesia Treatment Market Outlook, By Metabolic Disorders (2021-2030) ($MN)
22 Global Paresthesia Treatment Market Outlook, By Other Causes (2021-2030) ($MN)
23 Global Paresthesia Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
24 Global Paresthesia Treatment Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
25 Global Paresthesia Treatment Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
26 Global Paresthesia Treatment Market Outlook, By Online Pharmacy (2021-2030) ($MN)
27 Global Paresthesia Treatment Market Outlook, By Direct Tenders (2021-2030) ($MN)
28 Global Paresthesia Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
29 Global Paresthesia Treatment Market Outlook, By End User (2021-2030) ($MN)
30 Global Paresthesia Treatment Market Outlook, By Clinics (2021-2030) ($MN)
31 Global Paresthesia Treatment Market Outlook, By Homecare (2021-2030) ($MN)
32 Global Paresthesia Treatment Market Outlook, By Diagnosis Centers (2021-2030) ($MN)
33 Global Paresthesia Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
